These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24918192)

  • 41. [Declining costs].
    Neumaier J
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
    [No Abstract]   [Full Text] [Related]  

  • 42. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
.
    Cattaneo D; Andreoni M; Carosi G; Cauda R; Lazzarin A; Rizzardini G
    Int J Clin Pharmacol Ther; 2017 May; 55(5):381-393. PubMed ID: 28211784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
    Cohen J
    Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049
    [No Abstract]   [Full Text] [Related]  

  • 44. Generic stavudine approved.
    AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
    [No Abstract]   [Full Text] [Related]  

  • 45. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 46. Legal, ethical, and economic implications of breaking down once-daily fixed-dose antiretroviral combinations into their single components for cost reduction.
    Ramiro MA; Llibre JM
    Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):598-602. PubMed ID: 24139337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.
    Holmes CB; Coggin W; Jamieson D; Mihm H; Granich R; Savio P; Hope M; Ryan C; Moloney-Kitts M; Goosby EP; Dybul M
    JAMA; 2010 Jul; 304(3):313-20. PubMed ID: 20639565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. International. Rights group: U.S. blocking access to generic AIDS drugs.
    AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinton Foundation negotiates $140/Year HIV treatment, but U.S. won't buy.
    James JS
    AIDS Treat News; 2004 Mar; (399):2-4. PubMed ID: 15199865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The discovery and development of antiretroviral agents.
    Lange JM; Ananworanich J
    Antivir Ther; 2014; 19 Suppl 3():5-14. PubMed ID: 25310317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Just the medicine. Cheaper AIDS drugs.
    Whitelaw K
    US News World Rep; 2001 Mar; 130(12):31. PubMed ID: 11277041
    [No Abstract]   [Full Text] [Related]  

  • 52. Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries.
    Orsi F; d'almeida C
    Curr Opin HIV AIDS; 2010 May; 5(3):237-41. PubMed ID: 20539080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generic lamivudine and abacavir approved.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043839
    [No Abstract]   [Full Text] [Related]  

  • 54. Production of antiretroviral drugs in middle- and low-income countries.
    Pinheiro Edos S; Brüning K; Macedo MF; Siani AC
    Antivir Ther; 2014; 19 Suppl 3():49-55. PubMed ID: 25310755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. WHO pulls Indian generics off AIDS drugs list.
    Nat Med; 2004 Sep; 10(9):885. PubMed ID: 15340402
    [No Abstract]   [Full Text] [Related]  

  • 56. Generic drugs allowed in global trial of AIDS therapy.
    Check E
    Nature; 2004 Oct; 431(7012):1028. PubMed ID: 15510113
    [No Abstract]   [Full Text] [Related]  

  • 57. Closing the affordability gap for drugs in low-income countries.
    Steinbrook R
    N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
    [No Abstract]   [Full Text] [Related]  

  • 58. Generic and branded drugs for the treatment of people living with HIV/AIDS.
    Bartlett JA; Muro EP
    J Int Assoc Physicians AIDS Care (Chic); 2007 Mar; 6(1):15-23. PubMed ID: 17329500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generic drugs: the stalling game.
    Consum Rep; 2001 Jul; 66(7):36-40. PubMed ID: 11725791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AIDS treatment. A step toward cheaper anti-HIV therapy.
    Cohen J
    Science; 2005 Feb; 307(5710):653. PubMed ID: 15692020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.